| Indicators | Browse All

Medpace Holdings, Inc. (MEDP)

Healthcare | Diagnostics & Research | Cincinnati, United States | NasdaqGS
530.19 USD -8.04 (-1.494%) ⇩ (July 13, 2026, 4 p.m. EDT)

Short-term:★★★⯪☆Long-term:★★★★☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 5:29 a.m. EDT

Medpace presents a compelling case for long-term ownership driven by exceptional profitability and growth, yet the current price trades significantly above analyst expectations. The recent price surge has pushed the stock well above its 200-day average, creating a short-term bullish bias, but the lack of dividends and skepticism in recent earnings commentary suggest the upside may be capped until valuation compresses. For investors, this is a high-conviction long-term hold that requires patience, rather than a quick trade.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.059519
AutoARIMA0.070005
AutoETS0.071590
MSTL0.074142

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 27%
H-stat 104.96
Ljung-Box p 0.000
Jarque-Bera p 0.007
Excess Kurtosis 0.42
Attribute Value
Sector Healthcare
Debt to Equity Ratio 24.418
Revenue per Share 94.437
Market Cap 15,142,061,056
Trailing P/E 33.39
Forward P/E 28.10
Beta 1.15
Profit Margins 17.19%
Website https://www.medpace.com

As of July 11, 2026, 5:29 a.m. EDT: Speculators are positioning for volatility with heavy put protection at lower strikes (420-450) and call bets targeting upside beyond 600. Implied volatility is elevated for September expirations, indicating uncertainty around the mid-term horizon.


Info Dump

Attribute Value
52 Week Change 0.6800786
Address1 5,375 Medpace Way
All Time High 628.916
All Time Low 21.76
Ask 533.22
Ask Size 1
Audit Risk 6
Average Analyst Rating 2.9 - Hold
Average Daily Volume10 Day 332,290
Average Daily Volume3 Month 378,081
Average Volume 378,081
Average Volume10Days 332,290
Beta 1.151
Bid 525.06
Bid Size 1
Board Risk 8
Book Value 20.95
City Cincinnati
Compensation As Of Epoch Date 1,767,139,200
Compensation Risk 4
Country United States
Crypto Tradeable 0
Currency USD
Current Price 530.19
Current Ratio 0.847
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 544.418
Day Low 523.995
Debt To Equity 24.418
Display Name Medpace
Earnings Call Timestamp End 1,784,836,800
Earnings Call Timestamp Start 1,784,836,800
Earnings Growth 0.166
Earnings Quarterly Growth 0.081
Earnings Timestamp 1,784,750,400
Earnings Timestamp End 1,784,750,400
Earnings Timestamp Start 1,784,750,400
Ebitda 591,014,976
Ebitda Margins 0.22067
Enterprise To Ebitda 24.763
Enterprise To Revenue 5.465
Enterprise Value 14,635,474,944
Eps Current Year 17.17499
Eps Forward 18.86634
Eps Trailing Twelve Months 15.88
Esg Populated 0
Exchange NMS
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fax 513 579 0444
Fifty Day Average 463.2227
Fifty Day Average Change 66.967316
Fifty Day Average Change Percent 0.1445683
Fifty Two Week Change Percent 68.007866
Fifty Two Week High 628.916
Fifty Two Week High Change -98.72601
Fifty Two Week High Change Percent -0.15697806
Fifty Two Week Low 306.704
Fifty Two Week Low Change 223.486
Fifty Two Week Low Change Percent 0.72866994
Fifty Two Week Range 306.704 - 628.916
Financial Currency USD
First Trade Date Milliseconds 1,470,922,200,000
Float Shares 22,995,405
Forward Eps 18.86634
Forward P E 28.102428
Free Cashflow 490,738,880
Full Exchange Name NasdaqGS
Full Time Employees 6,300
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,782,864,000
Gross Margins 0.71900004
Gross Profits 1,925,682,048
Has Pre Post Market Data 1
Held Percent Insiders 0.19427
Held Percent Institutions 0.87362
Implied Shares Outstanding 28,559,689
Industry Diagnostics & Research
Industry Disp Diagnostics & Research
Industry Key diagnostics-research
Is Earnings Date Estimate 0
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Long Name Medpace Holdings, Inc.
Market us_market
Market Cap 15,142,061,056
Market State PRE
Max Age 86,400
Message Board Id finmb_260345878
Most Recent Quarter 1,774,915,200
Net Income To Common 460,398,016
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 15,141,490,317
Number Of Analyst Opinions 12
Open 527.275
Operating Cashflow 739,174,976
Operating Margins 0.20025998
Overall Risk 6
Payout Ratio 0.0
Peg Ratio 3.31
Phone 513 579 9911
Pre Market Change 0.039978027
Pre Market Change Percent 0.007540321
Pre Market Price 530.23
Pre Market Time 1,784,016,012
Previous Close 538.23
Price Eps Current Year 30.869888
Price Hint 2
Price To Book 25.307398
Price To Sales Trailing12 Months 5.653677
Profit Margins 0.1719
Quick Ratio 0.779
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key hold
Recommendation Mean 2.92308
Region US
Regular Market Change -8.03998
Regular Market Change Percent -1.49378
Regular Market Day High 544.418
Regular Market Day Low 523.995
Regular Market Day Range 523.995 - 544.418
Regular Market Open 527.275
Regular Market Previous Close 538.23
Regular Market Price 530.19
Regular Market Time 1,783,972,801
Regular Market Volume 261,761
Return On Assets 0.17473
Return On Equity 0.77252996
Revenue Growth 0.265
Revenue Per Share 94.437
Sand P52 Week Change 0.20847368
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 5
Shares Outstanding 28,559,689
Shares Percent Shares Out 0.0744
Shares Short 2,125,118
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 2,054,885
Short Name Medpace Holdings, Inc.
Short Percent Of Float 0.0923
Short Ratio 6.94
Source Interval 15
State OH
Symbol MEDP
Target High Price 586.0
Target Low Price 329.0
Target Mean Price 463.58334
Target Median Price 471.0
Total Cash 652,681,024
Total Cash Per Share 22.853
Total Debt 146,094,000
Total Revenue 2,678,267,904
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps 15.88
Trailing P E 33.38728
Trailing Peg Ratio 3.3091
Triggerable 1
Two Hundred Day Average 514.9376
Two Hundred Day Average Change 15.25238
Two Hundred Day Average Change Percent 0.02961986
Type Disp Equity
Volume 261,761
Website https://www.medpace.com
Zip 45,227